Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2001 Mar;54(3):163–175. doi: 10.1136/jcp.54.3.163

Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference

F Bosch 1, T Rohan 1, A Schneider 1, I Frazer 1, H Pfister 1, X Castellsague 1, S de Sanjose 1, V Moreno 1, L Puig-Tintore 1, P Smith 1, N Munoz 1, H zur Hausen 1
PMCID: PMC1731368  PMID: 11253126

Abstract

The 18th international papillomavirus conference took place in Barcelona, Spain in July 2000. The HPV clinical workshop was jointly organised with the annual meeting of the Spanish Association of Cervical Pathology and Colposcopy. The conference included 615 abstracts describing ongoing research in epidemiology, diagnosis/screening, treatment/prognosis, immunology/human immunodeficiency virus, vaccine development/trials, transformation/progression, replication, transcription/translation, viral protein functions, and viral and host interactions. This leader summarises the highlights presented at the conference (the full text of the abstracts and lectures can be found at www.hpv2000.com). Relevant material in Spanish can be found at www.aepcc.org.

Key Words: papillomavirus • epidemiology • immunology • biology • screening

Full Text

The Full Text of this article is available as a PDF (157.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cuzick J., Sasieni P., Davies P., Adams J., Normand C., Frater A., van Ballegooijen M., van den Akker E. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess. 1999;3(14):i-iv, 1-196. [PubMed] [Google Scholar]
  2. Harwood C. A., McGregor J. M., Proby C. M., Breuer J. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol. 1999 Apr;52(4):249–253. doi: 10.1136/jcp.52.4.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Holowaty P., Miller A. B., Rohan T., To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999 Feb 3;91(3):252–258. doi: 10.1093/jnci/91.3.252. [DOI] [PubMed] [Google Scholar]
  4. Kuhn L., Denny L., Pollack A., Lorincz A., Richart R. M., Wright T. C. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst. 2000 May 17;92(10):818–825. doi: 10.1093/jnci/92.10.818. [DOI] [PubMed] [Google Scholar]
  5. Manos M. M., Kinney W. K., Hurley L. B., Sherman M. E., Shieh-Ngai J., Kurman R. J., Ransley J. E., Fetterman B. J., Hartinger J. S., McIntosh K. M. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999 May 5;281(17):1605–1610. doi: 10.1001/jama.281.17.1605. [DOI] [PubMed] [Google Scholar]
  6. Meijer C. J., Walboomers J. M. Cervical cytology after 2000: where to go? J Clin Pathol. 2000 Jan;53(1):41–43. doi: 10.1136/jcp.53.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nobbenhuis M. A., Walboomers J. M., Helmerhorst T. J., Rozendaal L., Remmink A. J., Risse E. K., van der Linden H. C., Voorhorst F. J., Kenemans P., Meijer C. J. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999 Jul 3;354(9172):20–25. doi: 10.1016/S0140-6736(98)12490-X. [DOI] [PubMed] [Google Scholar]
  8. Ramoz N., Taïeb A., Rueda L. A., Montoya L. S., Bouadjar B., Favre M., Orth G. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol. 2000 Jun;114(6):1148–1153. doi: 10.1046/j.1523-1747.2000.00996.x. [DOI] [PubMed] [Google Scholar]
  9. Rozendaal L., Westerga J., van der Linden J. C., Walboomers J. M., Voorhorst F. J., Risse E. K., Boon M. E., Meijer C. J. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol. 2000 Aug;53(8):606–611. doi: 10.1136/jcp.53.8.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Salmon J., Nonnenmacher M., Cazé S., Flamant P., Croissant O., Orth G., Breitburd F. Variation in the nucleotide sequence of cottontail rabbit papillomavirus a and b subtypes affects wart regression and malignant transformation and level of viral replication in domestic rabbits. J Virol. 2000 Nov;74(22):10766–10777. doi: 10.1128/jvi.74.22.10766-10777.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schiffman M., Herrero R., Hildesheim A., Sherman M. E., Bratti M., Wacholder S., Alfaro M., Hutchinson M., Morales J., Greenberg M. D. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000 Jan 5;283(1):87–93. doi: 10.1001/jama.283.1.87. [DOI] [PubMed] [Google Scholar]
  12. Stubenrauch F., Hummel M., Iftner T., Laimins L. A. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J Virol. 2000 Feb;74(3):1178–1186. doi: 10.1128/jvi.74.3.1178-1186.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Vernon S. D., Unger E. R., Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol. 2000 Feb;38(2):651–655. doi: 10.1128/jcm.38.2.651-655.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  15. Wells S. I., Francis D. A., Karpova A. Y., Dowhanick J. J., Benson J. D., Howley P. M. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J. 2000 Nov 1;19(21):5762–5771. doi: 10.1093/emboj/19.21.5762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000 May 3;92(9):690–698. doi: 10.1093/jnci/92.9.690. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES